These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19056339)

  • 21. ING5 is phosphorylated by CDK2 and controls cell proliferation independently of p53.
    Linzen U; Lilischkis R; Pandithage R; Schilling B; Ullius A; Lüscher-Firzlaff J; Kremmer E; Lüscher B; Vervoorts J
    PLoS One; 2015; 10(4):e0123736. PubMed ID: 25860957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of guanidino analogues of roscovitine.
    Dolečková I; Cesnek M; Dračinský M; Brynda J; Voller J; Janeba Z; Kryštof V
    Eur J Med Chem; 2013 Apr; 62():443-52. PubMed ID: 23399722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclin A2 mutagenesis analysis: a new insight into CDK activation and cellular localization requirements.
    Bendris N; Lemmers B; Blanchard JM; Arsic N
    PLoS One; 2011; 6(7):e22879. PubMed ID: 21829545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cyclin A1-CDK2 complex regulates DNA double-strand break repair.
    Müller-Tidow C; Ji P; Diederichs S; Potratz J; Bäumer N; Köhler G; Cauvet T; Choudary C; van der Meer T; Chan WY; Nieduszynski C; Colledge WH; Carrington M; Koeffler HP; Restle A; Wiesmüller L; Sobczak-Thépot J; Berdel WE; Serve H
    Mol Cell Biol; 2004 Oct; 24(20):8917-28. PubMed ID: 15456866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated levels and distinct patterns of expression of A-type cyclins and their associated cyclin-dependent kinases in male germ cell tumors.
    Liao C; Li SQ; Wang X; Muhlrad S; Bjartell A; Wolgemuth DJ
    Int J Cancer; 2004 Feb; 108(5):654-64. PubMed ID: 14696091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cdc2 and Cdk2 kinase activated by transforming growth factor-beta1 trigger apoptosis through the phosphorylation of retinoblastoma protein in FaO hepatoma cells.
    Choi KS; Eom YW; Kang Y; Ha MJ; Rhee H; Yoon JW; Kim SJ
    J Biol Chem; 1999 Nov; 274(45):31775-83. PubMed ID: 10542199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes.
    Lundberg AS; Weinberg RA
    Mol Cell Biol; 1998 Feb; 18(2):753-61. PubMed ID: 9447971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of cell cycle regulators in tumor formation in transgenic mice expressing the human neurotropic virus, JCV, early protein.
    Krynska B; Gordon J; Otte J; Franks R; Knobler R; DeLuca A; Giordano A; Khalili K
    J Cell Biochem; 1997 Nov; 67(2):223-30. PubMed ID: 9328827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgen receptor regulation of G1 cyclin and cyclin-dependent kinase function in the CWR22 human prostate cancer xenograft.
    Gregory CW; Johnson RT; Presnell SC; Mohler JL; French FS
    J Androl; 2001; 22(4):537-48. PubMed ID: 11451350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair.
    Federico M; Symonds CE; Bagella L; Rizzolio F; Fanale D; Russo A; Giordano A
    Mol Cancer; 2010 Aug; 9():208. PubMed ID: 20684776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA damage response involves modulation of Ku70 and Rb functions by cyclin A1 in leukemia cells.
    Ji P; Bäumer N; Yin T; Diederichs S; Zhang F; Beger C; Welte K; Fulda S; Berdel WE; Serve H; Müller-Tidow C
    Int J Cancer; 2007 Aug; 121(4):706-13. PubMed ID: 17455244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cyclin box and C-terminus of cyclins A and E specify CDK activation and substrate specificity.
    Horton LE; Templeton DJ
    Oncogene; 1997 Jan; 14(4):491-8. PubMed ID: 9053846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclin A1/Cdk2 is sufficient but not required for the induction of apoptosis in early Xenopus laevis embryos.
    Carter AD; Wroble BN; Sible JC
    Cell Cycle; 2006 Oct; 5(19):2230-6. PubMed ID: 16969089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular basis for viral selective replication in cancer cells: activation of CDK2 by adenovirus-induced cyclin E.
    Cheng PH; Rao XM; McMasters KM; Zhou HS
    PLoS One; 2013; 8(2):e57340. PubMed ID: 23437375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct roles for the mammalian A-type cyclins during oogenesis.
    Persson JL; Zhang Q; Wang XY; Ravnik SE; Muhlrad S; Wolgemuth DJ
    Reproduction; 2005 Oct; 130(4):411-22. PubMed ID: 16183859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly potent p21(WAF1)-derived peptide inhibitors of CDK-mediated pRb phosphorylation: delineation and structural insight into their interactions with cyclin A.
    Zheleva DI; McInnes C; Gavine AL; Zhelev NZ; Fischer PM; Lane DP
    J Pept Res; 2002 Nov; 60(5):257-70. PubMed ID: 12383116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective cyclin-dependent kinase inhibitors discriminating between cell cycle and transcriptional kinases: future reality or utopia?
    Wesierska-Gadek J; Krystof V
    Ann N Y Acad Sci; 2009 Aug; 1171():228-41. PubMed ID: 19723060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-&-N, a new class of cell death-inducing kinase inhibitors derived from the purine roscovitine.
    Bettayeb K; Sallam H; Ferandin Y; Popowycz F; Fournet G; Hassan M; Echalier A; Bernard P; Endicott J; Joseph B; Meijer L
    Mol Cancer Ther; 2008 Sep; 7(9):2713-24. PubMed ID: 18790752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A.
    Luciani MG; Hutchins JR; Zheleva D; Hupp TR
    J Mol Biol; 2000 Jul; 300(3):503-18. PubMed ID: 10884347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New alternative phosphorylation sites on the cyclin dependent kinase 1/cyclin a complex in p53-deficient human cells treated with etoposide: possible association with etoposide-induced apoptosis.
    Higginbottom K; Jahnke U; Newland AC; Cotter FE; Allen PD
    Apoptosis; 2007 Oct; 12(10):1847-55. PubMed ID: 17636382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.